Since 1998, Wellington Partners has been helping outstanding entrepreneurs to turn their ideas into a reality and to become global leaders in their field of business. As a venture capital firm, we focus on early- and growth-stage life science companies from Germany, Europe and beyond, with breakthrough and truly innovative technologies. With a highly experienced team, a strong track record and a strongly diversified portfolio, we enable entrepreneurial vision and help to unlock potential.

58

life science investments

590

raised for life science funds

27

life science exits, IPOs & trade sales

Latest News

INVENTION & GROWTH

Funds & Investors

We are currently investing out of our fifth fund – our largest so far – which was considerably oversubscribed at its closing. Its size is more than double the volume of its predecessor. Thus, substantially funded, we have again been able to back the growth ambitions of some of Europe’s most outstanding start-ups in the sector so far.

Name

WPLS V

Investments

15

Volume

EUR 210m

Scope

Bio- & Med Tec

Together we grow:Our portfolio companies are our top priority.

Nyra Health

Digital neuro-rehabilitation platform

Adrenomed

Rescuing the vascular integrity in critically ill patients

Oxford Immunotec

Proprietary tests for immune-regulated conditions

Seamless Therapeutics

Unlocking the full potential of recombinases in gene editing